Results 81 to 90 of about 1,915,304 (214)

In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases

open access: yesCardiology Research and Practice, 2020
Coronary heart disease is a major cause of death and disability in developed countries. Stent implantation has become an efficacious treatment for a culprit lesion vessel of the coronary artery.
Dai-Min Zhang, Shaoliang Chen
doaj   +1 more source

When Subtle Guiding Catheter‐Induced Stent Deformation Leads to Abluminal Guidewire Passage: Successful IVUS Tip‐Detection‐Guided Bailout

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Incomplete stent apposition at the proximal coronary artery may predispose to subtle guiding catheter–induced stent deformation, creating a gap between the stent and the vessel wall that facilitates inadvertent abluminal guidewire passage. We report a case in which balloon dilatation over an unrecognized abluminal guidewire resulted in severe ...
Yuto Abe   +3 more
wiley   +1 more source

Drug eluting balloon angioplasty for assisted maturation of failing fistulae

open access: yes, 2018
Objective: To present our experience of balloon-assisted maturation with drug-eluting balloon dilation in patients with recurrent failing arteriovenous fistulae.
Myriam Combes   +4 more
core   +1 more source

Mechanisms and Management of Acquired Aseptic Intracardiac Communications After Transcatheter Aortic Valve Implantation: Single‐Center Case Series Insights

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Acquired aseptic intracardiac communications (AICCs) are rare but clinically relevant structural complications following transcatheter aortic valve implantation (TAVI), typically resulting from mechanical injury to the aortic annulus, interventricular septum, or adjacent structures.
Geza Fontos   +6 more
wiley   +1 more source

Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials

open access: yesBMC Cardiovascular Disorders, 2018
BackgroundDrug-eluting balloons (DEB) have significant value for treating coronary artery disease (CAD). However, the merits of using DEB versus drug-eluting stents (DES) to treat CAD remain controversial.
Lu-Lu Liu   +5 more
semanticscholar   +1 more source

Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis.

open access: yes, 2017
The success of drug-coated balloon therapy might be compromised by intraprocedural particulate embolisation of matrix coating, which may cause downstream microvascular obstruction.
Colleran, Roisin;Harada, Yukinori;Kufner, Sebastian;Giacoppo, Daniele;Joner, Michael;Cassese, Salvatore;Ibrahim, Tareq;Laugwitz, Karl-Ludwig;Kastrati, Adnan;Byrne, Robert A
core   +1 more source

Balloon‐Stopper Retrieval and Peripheral Parking After Inadvertent Ostial Right Coronary Stent Deployment

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Percutaneous treatment of right coronary artery (RCA) ostial lesions is technically challenging due to cardiorespiratory motion. Case Summary We describe a 70‐year‐old man undergoing PCI for an ostial RCA lesion where a forceful cough caused complete stent expansion within the aortic root.
Fernando Quevedo‐Candela   +2 more
wiley   +1 more source

Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries.

open access: yesCochrane Database of Systematic Reviews, 2017
BACKGROUND Stents are placed in the femoropopliteal arteries for numerous reasons, such as atherosclerotic disease, the need for dissection, and perforation of the arteries, and can become stenosed with the passage of time.
Ahmed Kayssi   +7 more
semanticscholar   +1 more source

Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: The nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial [PDF]

open access: yes, 2015
ObjectiveTo evaluate a paclitaxel drug-eluting balloon (DEB) only strategy in primary percutaneous coronary intervention (PPCI), aiming at a comparison with bare metal stent (BMS) alone, DEB followed by BMS, and paclitaxel eluting stent (PES), as ...
Agostoni, Pierfrancesco   +7 more
core   +1 more source

Implantable electrochemical sensors for continuous blood monitoring

open access: yesFlexMat, EarlyView.
Implantable electrochemical sensors enable direct, in situ, and continuous blood monitoring, shifting diagnosis from population‐based averages to dynamic, individualized analysis. This review systematically examines the influence of the unique blood properties on sensor design.
Kuangyi Zou   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy